肺结节抗炎后不吸收就建议切除?

2021-08-24 肺结节前沿 肺结节前沿

46男性,不吸烟。因感冒发热,做CT检查发现肺实性结节1.6cm。用了头孢加左氧消炎7天后,复查CT检查没有变化,当地继续予莫西沙星抗炎治疗中。

46男性,不吸烟。因感冒发热,做CT检查发现肺实性结节1.6cm。用了头孢加左氧消炎7天后,复查CT检查没有变化,当地继续予莫西沙星抗炎治疗中。

下图为首次抗炎后复查后的CT:为右上肺实性结节16mm。

由于抗炎后不吸收,有医生建议直接手术切除。

对于这种先切除再诊断再治疗的观念,窃以为极不可取。就算是微创楔形切除,毕竟也是切除了一小部分肺。只有极少数高危结节,其他方式无法确诊的情况下,才能考虑不管良恶性,切除后再诊断。

抗炎后不吸收,就要怀疑恶性,要切除吗?

观看CT这个结节还是典型的炎症性表现,符合普通细菌性炎症,仔细再看一下结节形态:

结节周围有斑点,符合炎症的表现:

结节较为分散,同样为炎症样表现:

另外,之前抗炎后复查时间太短(7天),炎症也可能不会吸收明显。而且,对于这种社区性肺部感染,选择莫西沙星或者奈诺沙星,是比头孢和左氧氟沙星更好的抗炎药物选择。

由于CT图像为典型炎症样表现炎症,没有建议患者做肿瘤标志物等进一步的血液检查,也不用做PET。

抗炎结束,后续1个月复查,结节明显吸收变淡,遗留磨玻璃影,这个磨玻璃,只是个炎症的吸收过程。而且形态上,这个磨玻璃边界不清,同样只是炎症的吸收过程。

来源:肺结节前沿

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1215648, encodeId=9c701215648df, content=就一例有一般性意义吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=188c2216074, createdName=120e75c7m17暂无昵称, createdTime=Fri Apr 29 18:55:58 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077473, encodeId=295e10e7473a4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59ff6145672, createdName=ms1000002043536403, createdTime=Mon Dec 06 20:14:51 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072880, encodeId=415510e2880a4, content=很好的经验, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e3a5419766, createdName=ms6000000800992147, createdTime=Mon Nov 22 16:07:57 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054039, encodeId=488010540394e, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Thu Sep 23 08:29:28 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010968, encodeId=1628101096821, content=病例很精彩,分析很全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3345583185, createdName=dream11, createdTime=Tue Aug 24 14:45:53 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010920, encodeId=011d1010920cd, content=学习了,获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/0c6eb4f5fee8448087495d56e0d2ae29/a6db9aa5bc1e46fca976ef34024b8bd1.jpg, createdBy=af7a5463863, createdName=鹅不吃草, createdTime=Tue Aug 24 11:01:35 CST 2021, time=2021-08-24, status=1, ipAttribution=)]
    2022-04-29 120e75c7m17暂无昵称

    就一例有一般性意义吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1215648, encodeId=9c701215648df, content=就一例有一般性意义吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=188c2216074, createdName=120e75c7m17暂无昵称, createdTime=Fri Apr 29 18:55:58 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077473, encodeId=295e10e7473a4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59ff6145672, createdName=ms1000002043536403, createdTime=Mon Dec 06 20:14:51 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072880, encodeId=415510e2880a4, content=很好的经验, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e3a5419766, createdName=ms6000000800992147, createdTime=Mon Nov 22 16:07:57 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054039, encodeId=488010540394e, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Thu Sep 23 08:29:28 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010968, encodeId=1628101096821, content=病例很精彩,分析很全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3345583185, createdName=dream11, createdTime=Tue Aug 24 14:45:53 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010920, encodeId=011d1010920cd, content=学习了,获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/0c6eb4f5fee8448087495d56e0d2ae29/a6db9aa5bc1e46fca976ef34024b8bd1.jpg, createdBy=af7a5463863, createdName=鹅不吃草, createdTime=Tue Aug 24 11:01:35 CST 2021, time=2021-08-24, status=1, ipAttribution=)]
    2021-12-06 ms1000002043536403

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1215648, encodeId=9c701215648df, content=就一例有一般性意义吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=188c2216074, createdName=120e75c7m17暂无昵称, createdTime=Fri Apr 29 18:55:58 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077473, encodeId=295e10e7473a4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59ff6145672, createdName=ms1000002043536403, createdTime=Mon Dec 06 20:14:51 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072880, encodeId=415510e2880a4, content=很好的经验, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e3a5419766, createdName=ms6000000800992147, createdTime=Mon Nov 22 16:07:57 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054039, encodeId=488010540394e, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Thu Sep 23 08:29:28 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010968, encodeId=1628101096821, content=病例很精彩,分析很全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3345583185, createdName=dream11, createdTime=Tue Aug 24 14:45:53 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010920, encodeId=011d1010920cd, content=学习了,获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/0c6eb4f5fee8448087495d56e0d2ae29/a6db9aa5bc1e46fca976ef34024b8bd1.jpg, createdBy=af7a5463863, createdName=鹅不吃草, createdTime=Tue Aug 24 11:01:35 CST 2021, time=2021-08-24, status=1, ipAttribution=)]
    2021-11-22 ms6000000800992147

    很好的经验

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1215648, encodeId=9c701215648df, content=就一例有一般性意义吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=188c2216074, createdName=120e75c7m17暂无昵称, createdTime=Fri Apr 29 18:55:58 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077473, encodeId=295e10e7473a4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59ff6145672, createdName=ms1000002043536403, createdTime=Mon Dec 06 20:14:51 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072880, encodeId=415510e2880a4, content=很好的经验, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e3a5419766, createdName=ms6000000800992147, createdTime=Mon Nov 22 16:07:57 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054039, encodeId=488010540394e, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Thu Sep 23 08:29:28 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010968, encodeId=1628101096821, content=病例很精彩,分析很全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3345583185, createdName=dream11, createdTime=Tue Aug 24 14:45:53 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010920, encodeId=011d1010920cd, content=学习了,获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/0c6eb4f5fee8448087495d56e0d2ae29/a6db9aa5bc1e46fca976ef34024b8bd1.jpg, createdBy=af7a5463863, createdName=鹅不吃草, createdTime=Tue Aug 24 11:01:35 CST 2021, time=2021-08-24, status=1, ipAttribution=)]
    2021-09-23 鸿毳沉舟

    学习了。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1215648, encodeId=9c701215648df, content=就一例有一般性意义吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=188c2216074, createdName=120e75c7m17暂无昵称, createdTime=Fri Apr 29 18:55:58 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077473, encodeId=295e10e7473a4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59ff6145672, createdName=ms1000002043536403, createdTime=Mon Dec 06 20:14:51 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072880, encodeId=415510e2880a4, content=很好的经验, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e3a5419766, createdName=ms6000000800992147, createdTime=Mon Nov 22 16:07:57 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054039, encodeId=488010540394e, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Thu Sep 23 08:29:28 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010968, encodeId=1628101096821, content=病例很精彩,分析很全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3345583185, createdName=dream11, createdTime=Tue Aug 24 14:45:53 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010920, encodeId=011d1010920cd, content=学习了,获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/0c6eb4f5fee8448087495d56e0d2ae29/a6db9aa5bc1e46fca976ef34024b8bd1.jpg, createdBy=af7a5463863, createdName=鹅不吃草, createdTime=Tue Aug 24 11:01:35 CST 2021, time=2021-08-24, status=1, ipAttribution=)]
    2021-08-24 dream11

    病例很精彩,分析很全面

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1215648, encodeId=9c701215648df, content=就一例有一般性意义吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=188c2216074, createdName=120e75c7m17暂无昵称, createdTime=Fri Apr 29 18:55:58 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077473, encodeId=295e10e7473a4, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59ff6145672, createdName=ms1000002043536403, createdTime=Mon Dec 06 20:14:51 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072880, encodeId=415510e2880a4, content=很好的经验, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e3a5419766, createdName=ms6000000800992147, createdTime=Mon Nov 22 16:07:57 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054039, encodeId=488010540394e, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Thu Sep 23 08:29:28 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010968, encodeId=1628101096821, content=病例很精彩,分析很全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3345583185, createdName=dream11, createdTime=Tue Aug 24 14:45:53 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010920, encodeId=011d1010920cd, content=学习了,获益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/0c6eb4f5fee8448087495d56e0d2ae29/a6db9aa5bc1e46fca976ef34024b8bd1.jpg, createdBy=af7a5463863, createdName=鹅不吃草, createdTime=Tue Aug 24 11:01:35 CST 2021, time=2021-08-24, status=1, ipAttribution=)]
    2021-08-24 鹅不吃草

    学习了,获益匪浅

    0

相关资讯

肺结节术中切下来摸不到----怎么办?

肺部结节很小,很多医院是没有定位的,所以经常会碰到肺组织楔切下来,但是结节找不到的情况,这时候就处于两难,是扩大切?还是关掉呢?

Radiology:用胸片筛查肺癌结节,你放心吗?人工智能给你答案!

肺癌是全世界癌症相关死亡的主要原因,占所有癌症死亡人数的四分之一。由于大多数情况下肺癌诊断时已为晚期,因此肺癌的早期筛查已成为降低肺癌死亡率的重要策略。

Radiology:你还在为胸部X线片上的胸部X线片烦恼吗?

胸部X线片是最常用的影像学检查之一。多项研究表明,当对基线胸部X线片进行重新检查时,高达90%的“遗漏”肺癌结节可以被发现,且显示肿块的大小已经增大。

Radiology:卷积神经网络,使评估肺结节每天的体积变化成为可能!

美国国家肺部筛查试验显示,低剂量CT筛查肺癌是一种可降低总死亡率的具有经济效益的检查手段。

Radiology:计算机辅助识别肺结节虽好,仍需慎用!

应用于胸部CT扫描的计算机辅助检测(CAD)系统可作为第二阅读器检测有意义的结节,并有助于减少结节漏诊情况的发生,特别是在减少错误和提高工作效率方面效果显著。